Header Logo

Connection

CHING-WEI DAVID TZENG to Neoplasm Staging

Back to Details
This is a "connection" page, showing publications CHING-WEI DAVID TZENG has written about Neoplasm Staging.
CHING-WEI DAVID TZENG
Connection Strength
0.975
Neoplasm Staging
  1. Locally Advanced Pancreas Cancer, Is There a Role for Surgery? Surg Clin North Am. 2024 Oct; 104(5):1017-1030.
    View in: PubMed
    Score: 0.079
  2. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol. 2022 Mar; 40:101673.
    View in: PubMed
    Score: 0.067
  3. Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer. Ann Surg. 2021 04 01; 273(4):806-813.
    View in: PubMed
    Score: 0.064
  4. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Ann Surg. 2020 06; 271(6):996-1002.
    View in: PubMed
    Score: 0.060
  5. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg. 2020 02; 107(3):289-300.
    View in: PubMed
    Score: 0.058
  6. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB (Oxford). 2019 09; 21(9):1203-1210.
    View in: PubMed
    Score: 0.055
  7. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res. 2018 10; 230:148-154.
    View in: PubMed
    Score: 0.052
  8. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases. Br J Surg. 2018 08; 105(9):1200-1209.
    View in: PubMed
    Score: 0.052
  9. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018 01; 44(1):122-129.
    View in: PubMed
    Score: 0.051
  10. Does finding early recurrence improve outcomes, and at what cost? J Surg Oncol. 2016 Sep; 114(3):329-35.
    View in: PubMed
    Score: 0.046
  11. Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis. J Surg Oncol. 2016 Sep; 114(4):451-5.
    View in: PubMed
    Score: 0.046
  12. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.035
  13. Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol. 2012 Jun; 19(6):2045-53.
    View in: PubMed
    Score: 0.034
  14. Soft tissue sarcoma: preoperative and postoperative imaging for staging. Surg Oncol Clin N Am. 2007 Apr; 16(2):389-402.
    View in: PubMed
    Score: 0.024
  15. ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9. Ann Surg Oncol. 2024 03; 31(3):1842-1843.
    View in: PubMed
    Score: 0.019
  16. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol. 2023 04 01; 47(4):421-430.
    View in: PubMed
    Score: 0.018
  17. Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors. J Surg Res. 2021 12; 268:419-431.
    View in: PubMed
    Score: 0.016
  18. Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis. Ann Surg Oncol. 2021 May; 28(5):2675-2682.
    View in: PubMed
    Score: 0.016
  19. Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer. Ann Surg Oncol. 2021 Jun; 28(6):2960-2972.
    View in: PubMed
    Score: 0.016
  20. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology. 2021 Jan; 21(1):200-207.
    View in: PubMed
    Score: 0.016
  21. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation. J Am Coll Surg. 2019 09; 229(3):286-294.e1.
    View in: PubMed
    Score: 0.014
  22. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB (Oxford). 2019 08; 21(8):1046-1056.
    View in: PubMed
    Score: 0.014
  23. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.
    View in: PubMed
    Score: 0.013
  24. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer. 2018 04 15; 124(8):1701-1709.
    View in: PubMed
    Score: 0.013
  25. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy. J Gastrointest Surg. 2018 04; 22(4):703-712.
    View in: PubMed
    Score: 0.013
  26. Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 Mar; 23(3):1003-11.
    View in: PubMed
    Score: 0.011
  27. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1221-8.
    View in: PubMed
    Score: 0.011
  28. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncol. 2016; 55(3):265-77.
    View in: PubMed
    Score: 0.011
  29. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
    View in: PubMed
    Score: 0.010
  30. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system. Ann Surg Oncol. 2013 Dec; 20(13):4073-9.
    View in: PubMed
    Score: 0.009
  31. Treatment of borderline resectable pancreatic cancer. Curr Treat Options Oncol. 2013 Sep; 14(3):293-310.
    View in: PubMed
    Score: 0.009
  32. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
    View in: PubMed
    Score: 0.009
  33. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg. 2009 Jun; 46(6):445-503.
    View in: PubMed
    Score: 0.007
  34. Radiofrequency ablation for unresectable tumors of the liver. Am Surg. 2008 Jul; 74(7):594-600; discussion 600-1.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.